Opioid and controlled-substance prescribing CME requirements by state

Reviewed by CME Psychiatry Center editorsLast reviewed against state medical-board rulesHow we verify

Most states now require some opioid, pain-management or controlled-substance prescribing education as a condition of renewal, and the federal DEA MATE Act separately requires a one-time 8 hours on treating and managing patients with opioid or other substance use disorders before a DEA registration is issued or renewed. For a psychiatrist the practical question is which single activity satisfies the most rules at once. The table lists the state mandate; open a state for the psychiatrist-specific reading.

Coverage: 9 of 51 state pages have been migrated to structured rules so far; states not yet migrated do not appear here even if they have a mandate. See the full state table.

StateRequirementHoursHow oftenApplies toCounts toward totalRuleReviewed
CaliforniaPain management and treatment of terminally ill and dying patients (incl. Schedule II addiction risks if licensed on/after 1/1/2019)12onceall physicians except pathologists and radiologists; waivable for physicians without direct patient care or residing outside CaliforniaYesBPC §2190.5; 16 CCR §1337
FloridaPrescribing controlled substances (opioids, alternatives, naloxone; sickle-cell pain management from July 1, 2026)2every renewalphysicians registered with the DEAYesFla. Stat. 456.0301; Fla. Admin. Code R. 64B8-13.005
IllinoisSafe opioid prescribing practices1every Controlled Substance Registration renewal (no first-renewal exemption); 1 hour is the current rule for renewals on/after Jan 1, 2025 (older IDFPR forms citing 3 hours are out of date)prescribers holding an Illinois Controlled Substance RegistrationYes720 ILCS 570/315.5 (as amended by P.A. 103-531, eff. 1-1-25)
New JerseyPrescription opioid drugs (responsible prescribing, alternatives, abuse and addiction)1every renewalAll licenseesYesN.J.A.C. 13:35-6.15(d)
New YorkPain management, palliative care and addiction (8 required content areas incl. state and federal prescribing rules, screening for addiction, end-of-life care)3once within each 3-year periodlicensed prescribers with a DEA registration number (incl. residents prescribing under a facility DEA number)NoPublic Health Law § 3309-a(3)
North CarolinaControlled-substance prescribing practices (must cover prescribing practices and chronic pain management; abuse/misuse recognition and non-opioid options also qualify)3every renewalphysicians who prescribe any controlled substance (excludes residency training licensees)Yes21 NCAC 32R .0101(b)
OhioPain medicine, including the potential for addiction20every renewalphysician owners, operators, and physicians providing care at pain management clinicsYesOAC 4731-29-01
PennsylvaniaPain management, identification of addiction, or opioid prescribing/dispensing (Act 124)2every renewalphysicians who hold a DEA registration or prescribe controlled substances under another entity's DEA numberYesAct 124 of 2016 (ABC-MAP Act); 49 Pa. Code § 16.19(b)(1)
TexasPain management and opioid prescribing2first two renewals (first within 1 year of licensure), then every 8 yearsphysicians in direct patient careYesTex. Occ. Code §156.055

Free ABPN + state CME planner

Are you on track for your ABPN deadline?

Tell us where you stand and we'll calculate exactly what's left in your current 3-year block — then email you a plan you can actually follow:

Already completed in this block (optional — leave blank if unsure)

Your plan arrives after a one-click confirmation. After that, only your three deadline reminders and any requirement changes; unsubscribe anytime. Figures from the ABPN CC Booklet (June 2025) and CC FAQ (April 2026).